 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1dqt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
1 term
|
 |
|
Biological process
|
immune response
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Science
290:816-819
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
|
|
D.A.Ostrov,
W.Shi,
J.C.Schwartz,
S.C.Almo,
S.G.Nathenson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The effective regulation of T cell responses is dependent on opposing signals
transmitted through two related cell-surface receptors, CD28 and cytotoxic T
lymphocyte-associated antigen 4 (CTLA-4). Dimerization of CTLA-4 is required for
the formation of high-avidity complexes with B7 ligands and for transmission of
signals that attenuate T cell activation. We determined the crystal structure of
the extracellular portion of CTLA-4 to 2.0 angstrom resolution. CTLA-4 belongs
to the immunoglobulin superfamily and displays a strand topology similar to
Valpha domains, with an unusual mode of dimerization that places the B7 binding
sites distal to the dimerization interface. This organization allows each CTLA-4
dimer to bind two bivalent B7 molecules and suggests that a periodic arrangement
of these components within the immunological synapse may contribute to the
regulation of T cell responsiveness.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Structure of CTLA-4. (A) On the right, ribbon diagram
of the CTLA-4 monomer. The strands
are labeled: A (3 to 6), A' (7 to 11), B (16 to 24), C (30 to
39), C' (43 to 53), C" (56 to 59), D (65 to 70), E (74 to 80), F
(87 to 99), and G (103 to 114). The A'GFCC' (front) and ABEDC"
(back) sheets are shown in gold and blue, respectively.
Intersheet disulfide bonds between the B and F strands and
between the C' and D strands are shown in yellow. Inset on the
top left shows the strand topology for typical v-type
immunoglobulin domains (e.g., V[H], V[L], V ). Inset on
the bottom left shows the strand topology for V domains
and CTLA-4 in which the C" strand is part of the back sheet. (B)
Ribbon diagram of the CTLA-4 dimer. The CTLA-4 homodimer is
oriented with the molecular diad axis situated vertically in the
plane of the page. In this orientation, the COOH-termini extend
from the bottom of the molecule. The dimer interface is formed
primarily by the ABEDC" (back) sheets, shown in blue. The CDR
analogous regions, CDR1 (BC loop), CDR2 (C'C" loop), and CDR3
(FG loop), form the top surface of the molecule. The distance
between the CDR3 analogous regions in the dimer is 47 Å.
(C) Detailed view of the CTLA-4 dimer interface. The twofold
axis of the dimer is perpendicular to the page. The backbones of
the CTLA-4 monomers are shown in green and in sky blue. The side
chains involved in hydrogen bonding and van der Waals
interactions at the dimer interface are displayed (23), with C,
O, and N atoms depicted in yellow, red, and blue, respectively.
Figure 1 was made with the program SETOR (41).
|
 |
Figure 3.
Fig. 3. B7 binding sites on CTLA-4 and placement of CDR3
regions in dimers of immunoglobulin domains. The molecular
surfaces of the TCR V V heterodimer
(1tcr) and the CTLA-4 homodimer (1dqt) are shown in (A) and (B),
respectively, with the CTLA-4 twofold axis oriented
perpendicular to the page. Because of front-to-front packing in
the TCR, the CDR3 regions shown in red are juxtaposed at the
dimer interface (A), whereas the back-to-back packing present in
CTLA-4 positions the CDR3 regions distal to the dimer interface
(B). The two B7 binding sites on the CTLA-4 homodimer, as mapped
by mutagenesis (26), include the FG loop (CDR3) shown in red,
the BC loop (CDR1) shown in yellow, and solvent-accessible
residues on the A'GFCC' sheet (Glu31, Arg33, Glu46, Lys93,
Glu95, Phe^103, and Val104), shown in yellow (18). In contrast
to V V and Fab,
which are monovalent for their respective ligands (i.e.,
peptide-MHC complex and antigen), the placement of ligand
binding sites at the extremes of the CTLA-4 dimer suggests that
each CTLA-4 monomer may interact with an individual B7 dimer.
(A) and (B) were prepared with GRASP (45). (C) Model of
organized interactions between CTLA-4 and B7 dimers in the
immunological synapse. CTLA-4 dimers, shown in red, are depicted
with their COOH-termini modeled to include the disulfide bond at
Cys120 near the T cell plasma membrane. CTLA-4 was manually
docked to B7-1 d1, shown in light blue, to maximize the
interaction between residues implicated by site-directed
mutagenesis, in particular, CDR3 (Met97TyrProProProTyr102) of
CTLA-4, and a hydrophobic patch on the A'GFCC'C" face of B7-1
(25). Each CTLA-4 dimer is depicted as binding two independent
B7 dimers with an intermolecular spacing of approximately 77
Å and an intermembrane distance spanned by the CTLA-4-B7
ligand pair of approximately 100 Å. (C) was made with the
program SETOR (41).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the AAAs:
Science
(2000,
290,
816-819)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.F.Sonnen,
C.Yu,
E.J.Evans,
D.I.Stuart,
S.J.Davis,
and
R.J.Gilbert
(2010).
Domain metastability: a molecular basis for immunoglobulin deposition?
|
| |
J Mol Biol, 399,
207-213.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Radaev,
Z.Zou,
P.Tolar,
K.Nguyen,
A.Nguyen,
P.D.Krueger,
N.Stutzman,
S.Pierce,
and
P.D.Sun
(2010).
Structural and functional studies of Igalphabeta and its assembly with the B cell antigen receptor.
|
| |
Structure, 18,
934-943.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.Ise,
M.Kohyama,
K.M.Nutsch,
H.M.Lee,
A.Suri,
E.R.Unanue,
T.L.Murphy,
and
K.M.Murphy
(2010).
CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms.
|
| |
Nat Immunol, 11,
129-135.
|
 |
|
|
|
|
 |
D.Schönfeld,
G.Matschiner,
L.Chatwell,
S.Trentmann,
H.Gille,
M.Hülsmeyer,
N.Brown,
P.M.Kaye,
S.Schlehuber,
A.M.Hohlbaum,
and
A.Skerra
(2009).
An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies.
|
| |
Proc Natl Acad Sci U S A, 106,
8198-8203.
|
 |
|
|
|
|
 |
G.Dultz,
M.Dittmar,
and
G.J.Kahaly
(2009).
[Genetics of thyroid autoimmunity - update and clinical relevance.]
|
| |
Med Klin (Munich), 104,
210-219.
|
 |
|
|
|
|
 |
H.Q.Qu,
J.P.Bradfield,
S.F.Grant,
H.Hakonarson,
and
C.Polychronakos
(2009).
Remapping the type I diabetes association of the CTLA4 locus.
|
| |
Genes Immun, 10,
S27-S32.
|
 |
|
|
|
|
 |
K.Chattopadhyay,
E.Lazar-Molnar,
Q.Yan,
R.Rubinstein,
C.Zhan,
V.Vigdorovich,
U.A.Ramagopal,
J.Bonanno,
S.G.Nathenson,
and
S.C.Almo
(2009).
Sequence, structure, function, immunity: structural genomics of costimulation.
|
| |
Immunol Rev, 229,
356-386.
|
 |
|
|
|
|
 |
R.H.Friedline,
D.S.Brown,
H.Nguyen,
H.Kornfeld,
J.Lee,
Y.Zhang,
M.Appleby,
S.D.Der,
J.Kang,
and
C.A.Chambers
(2009).
CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance.
|
| |
J Exp Med, 206,
421-434.
|
 |
|
|
|
|
 |
T.Pentcheva-Hoang,
E.Corse,
and
J.P.Allison
(2009).
Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.
|
| |
Immunol Rev, 229,
67-87.
|
 |
|
|
|
|
 |
E.Lázár-Molnár,
Q.Yan,
E.Cao,
U.Ramagopal,
S.G.Nathenson,
and
S.C.Almo
(2008).
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2.
|
| |
Proc Natl Acad Sci U S A, 105,
10483-10488.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Kim,
O.Turovskaya,
M.Levin,
F.R.Byrne,
J.S.Whoriskey,
J.G.McCabe,
and
M.Kronenberg
(2008).
Spontaneous colitis occurrence in transgenic mice with altered B7-mediated costimulation.
|
| |
J Immunol, 181,
5278-5288.
|
 |
|
|
|
|
 |
R.Eri,
K.N.Kodumudi,
D.J.Summerlin,
and
M.Srinivasan
(2008).
Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease.
|
| |
Inflamm Bowel Dis, 14,
458-470.
|
 |
|
|
|
|
 |
B.S.Clay,
and
A.I.Sperling
(2007).
T-cell costimulation blockade in immunologic diseases: role of CD28 family members.
|
| |
Expert Rev Clin Immunol, 3,
383-393.
|
 |
|
|
|
|
 |
M.B.Atkins,
D.Carbone,
G.Coukos,
M.Dhodapkar,
M.S.Ernstoff,
J.Finke,
T.F.Gajewski,
J.Gollob,
M.T.Lotze,
W.Storkus,
and
L.M.Weiner
(2007).
Report on the ISBTC mini-symposium on biologic effects of targeted therapeutics.
|
| |
J Immunother (1997), 30,
577-590.
|
 |
|
|
|
|
 |
P.Reichardt,
B.Dornbach,
and
M.Gunzer
(2007).
The molecular makeup and function of regulatory and effector synapses.
|
| |
Immunol Rev, 218,
165-177.
|
 |
|
|
|
|
 |
A.J.Hueber,
F.G.Matzkies,
M.Rahmeh,
B.Manger,
J.R.Kalden,
and
T.Nagel
(2006).
CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas.
|
| |
Immunol Cell Biol, 84,
51-58.
|
 |
|
|
|
|
 |
J.A.Hernández Prada,
R.N.Haire,
M.Allaire,
J.Jakoncic,
V.Stojanoff,
J.P.Cannon,
G.W.Litman,
and
D.A.Ostrov
(2006).
Ancient evolutionary origin of diversified variable regions demonstrated by crystal structures of an immune-type receptor in amphioxus.
|
| |
Nat Immunol, 7,
875-882.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.A.Teft,
M.G.Kirchhof,
and
J.Madrenas
(2006).
A molecular perspective of CTLA-4 function.
|
| |
Annu Rev Immunol, 24,
65-97.
|
 |
|
|
|
|
 |
D.A.Chistiakov
(2005).
Immunogenetics of Hashimoto's thyroiditis.
|
| |
J Autoimmune Dis, 2,
1.
|
 |
|
|
|
|
 |
E.J.Evans,
R.M.Esnouf,
R.Manso-Sancho,
R.J.Gilbert,
J.R.James,
C.Yu,
J.A.Fennelly,
C.Vowles,
T.Hanke,
B.Walse,
T.Hünig,
P.Sørensen,
D.I.Stuart,
and
S.J.Davis
(2005).
Crystal structure of a soluble CD28-Fab complex.
|
| |
Nat Immunol, 6,
271-279.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Okazaki,
and
J.Wang
(2005).
PD-1/PD-L pathway and autoimmunity.
|
| |
Autoimmunity, 38,
353-357.
|
 |
|
|
|
|
 |
T.Pentcheva-Hoang,
J.G.Egen,
K.Wojnoonski,
and
J.P.Allison
(2004).
B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.
|
| |
Immunity, 21,
401-413.
|
 |
|
|
|
|
 |
X.Zhang,
J.C.Schwartz,
X.Guo,
S.Bhatia,
E.Cao,
M.Lorenz,
M.Cammer,
L.Chen,
Z.Y.Zhang,
M.A.Edidin,
S.G.Nathenson,
and
S.C.Almo
(2004).
Structural and functional analysis of the costimulatory receptor programmed death-1.
|
| |
Immunity, 20,
337-347.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.E.Prota,
J.A.Campbell,
P.Schelling,
J.C.Forrest,
M.J.Watson,
T.R.Peters,
M.Aurrand-Lions,
B.A.Imhof,
T.S.Dermody,
and
T.Stehle
(2003).
Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding.
|
| |
Proc Natl Acad Sci U S A, 100,
5366-5371.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.P.Nayak,
G.Sailaja,
and
A.M.Jabbar
(2003).
Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4.
|
| |
J Virol, 77,
10850-10861.
|
 |
|
|
|
|
 |
D.H.Margulies
(2003).
CD28, costimulator or agonist receptor?
|
| |
J Exp Med, 197,
949-953.
|
 |
|
|
|
|
 |
F.Lühder,
Y.Huang,
K.M.Dennehy,
C.Guntermann,
I.Müller,
E.Winkler,
T.Kerkau,
S.Ikemizu,
S.J.Davis,
T.Hanke,
and
T.Hünig
(2003).
Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists.
|
| |
J Exp Med, 197,
955-966.
|
 |
|
|
|
|
 |
J.H.Wang,
and
M.J.Eck
(2003).
Assembling atomic resolution views of the immunological synapse.
|
| |
Curr Opin Immunol, 15,
286-293.
|
 |
|
|
|
|
 |
M.L.Baroja,
and
J.Madrenas
(2003).
Viewpoint: therapeutic implications of CTLA-4 compartmentalization.
|
| |
Am J Transplant, 3,
919-926.
|
 |
|
|
|
|
 |
P.A.van der Merwe,
and
S.J.Davis
(2003).
Molecular interactions mediating T cell antigen recognition.
|
| |
Annu Rev Immunol, 21,
659-684.
|
 |
|
|
|
|
 |
S.Radaev,
M.Kattah,
B.Rostro,
M.Colonna,
and
P.D.Sun
(2003).
Crystal structure of the human myeloid cell activating receptor TREM-1.
|
| |
Structure, 11,
1527-1535.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Wang,
J.Bajorath,
D.B.Flies,
H.Dong,
T.Honjo,
and
L.Chen
(2003).
Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction.
|
| |
J Exp Med, 197,
1083-1091.
|
 |
|
|
|
|
 |
T.Saito,
and
S.Yamasaki
(2003).
Negative feedback of T cell activation through inhibitory adapters and costimulatory receptors.
|
| |
Immunol Rev, 192,
143-160.
|
 |
|
|
|
|
 |
T.Stehle,
and
T.S.Dermody
(2003).
Structural evidence for common functions and ancestry of the reovirus and adenovirus attachment proteins.
|
| |
Rev Med Virol, 13,
123-132.
|
 |
|
|
|
|
 |
P.J.Darlington,
M.L.Baroja,
T.A.Chau,
E.Siu,
V.Ling,
B.M.Carreno,
and
J.Madrenas
(2002).
Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation.
|
| |
J Exp Med, 195,
1337-1347.
|
 |
|
|
|
|
 |
R.J.Greenwald,
Y.E.Latchman,
and
A.H.Sharpe
(2002).
Negative co-receptors on lymphocytes.
|
| |
Curr Opin Immunol, 14,
391-396.
|
 |
|
|
|
|
 |
C.A.Chambers,
M.S.Kuhns,
J.G.Egen,
and
J.P.Allison
(2001).
CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
|
| |
Annu Rev Immunol, 19,
565-594.
|
 |
|
|
|
|
 |
C.A.Chambers
(2001).
The expanding world of co-stimulation: the two-signal model revisited.
|
| |
Trends Immunol, 22,
217-223.
|
 |
|
|
|
|
 |
M.L.Alegre,
K.A.Frauwirth,
and
C.B.Thompson
(2001).
T-cell regulation by CD28 and CTLA-4.
|
| |
Nat Rev Immunol, 1,
220-228.
|
 |
|
|
|
|
 |
S.Z.Liu,
S.Z.Jin,
X.D.Liu,
and
Y.M.Sun
(2001).
Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes.
|
| |
BMC Immunol, 2,
8.
|
 |
|
|
|
|
 |
T.K.Varma,
T.E.Toliver-Kinsky,
C.Y.Lin,
A.P.Koutrouvelis,
J.E.Nichols,
and
E.R.Sherwood
(2001).
Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice.
|
| |
Infect Immun, 69,
5249-5263.
|
 |
|
|
|
|
 |
X.Zhang,
J.C.Schwartz,
S.G.Nathenson,
and
S.C.Almo
(2001).
Crystallization and preliminary X-ray analysis of the complex between human CTLA-4 and B7-2.
|
| |
Acta Crystallogr D Biol Crystallogr, 57,
898-899.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|